Astrazeneca (AZN) reported $12.02 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 7.3$0.73 for the same period compares to $0.69 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$12.07 billion, representing a surprise of -0.42%. The company delivered an EPS surprise of -1.35%, with the consensus EPS estimate being $0.74.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...